Zymeworks (ZYME) Operating Leases (2021 - 2026)
Zymeworks recorded quarterly Operating Leases of $13.8 million in Q1 2026, down 24.66% quarter-over-quarter from $18.3 million in Q4 2025, and down 25.33% year-over-year from $18.4 million in Q1 2025.
Zymeworks' Operating Leases history runs 6 years deep, the most recent figure standing at $13.8 million for Q1 2026.
- In Q1 2026, Operating Leases fell 25.33% year-over-year to $13.8 million; the TTM figure through Mar 2026 stood at $13.8 million (down 25.33% YoY), while the FY2025 annual figure was $18.3 million, down 1.44% from the prior year.
- Operating Leases came in at $13.8 million for Q1 2026 at Zymeworks, down from $18.3 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $29.9 million in Q3 2022 to a low of $13.8 million in Q1 2026.
- A 5-year average of $21.8 million and a median of $20.3 million in 2024 frame the typical range for Operating Leases.
- On a YoY basis, Operating Leases climbed as much as 5.39% in 2024 and fell as far as 30.72% in 2024.
- Zymeworks' Operating Leases stood at $28.1 million in 2022, then decreased by 4.9% to $26.8 million in 2023, then plunged by 30.72% to $18.5 million in 2024, then declined by 1.44% to $18.3 million in 2025, then retreated by 24.66% to $13.8 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $13.8 million, $18.3 million, and $18.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.76 Mn |
| Dec 31, 2025 | 18.27 Mn |
| Sep 30, 2025 | 18.90 Mn |
| Jun 30, 2025 | 15.09 Mn |
| Mar 31, 2025 | 18.43 Mn |
| Dec 31, 2024 | 18.53 Mn |
| Sep 30, 2024 | 20.28 Mn |
| Jun 30, 2024 | 20.03 Mn |
| Mar 31, 2024 | 25.13 Mn |
| Dec 31, 2023 | 26.75 Mn |
| Sep 30, 2023 | 26.25 Mn |
| Jun 30, 2023 | 23.49 Mn |
| Mar 31, 2023 | 23.85 Mn |
| Dec 31, 2022 | 28.13 Mn |
| Sep 30, 2022 | 29.94 Mn |
| Dec 31, 2021 | 30.92 Mn |